NCT00452842

Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials.

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 26,784 (planned)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 10 Years
• Healthy volunteers: Not accepted

Summary

An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.

Detailed description

Study A5091075, an observational study in subjects who had previously been treated with torcetrapib, was terminated on 20 Dec 2007. The study was terminated following reviews of final safety information from prior torcetrapib studies and the low participation rates observed during the recruitment period for study A5091075 . On the basis of this new information the Sponsor determined that it was unlikely that this study would result in new and scientifically valid information.

Conditions

• Cardiovascular Disease
• Cerebrovascular Disorders

Timeline

• Start date: 2007-10-01
• First posted: 2007-03-28
• Last updated: 2008-02-22

Locations

1 site across 1 country: United States